Published in Br J Cancer on January 13, 2003
Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer (2003) 4.40
Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ (2009) 4.18
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest (2004) 4.03
Health and economic implications of HPV vaccination in the United States. N Engl J Med (2008) 3.81
Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer (2004) 2.33
Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med (2006) 2.10
A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev (2008) 2.10
Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol (2008) 1.90
Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer (2006) 1.83
Papillomavirus infection in rural women in southern India. Br J Cancer (2005) 1.79
Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests. J Clin Microbiol (2006) 1.78
Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Res (2009) 1.67
Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J Clin Microbiol (2007) 1.66
Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis (2005) 1.65
Human papillomavirus infection in Shenyang City, People's Republic of China: A population-based study. Br J Cancer (2006) 1.62
Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK. Br J Cancer (2006) 1.57
Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol (2005) 1.57
Human papillomavirus and HPV vaccines: a review. Bull World Health Organ (2007) 1.55
Epidemiology of ocular surface squamous neoplasia in Africa. Trop Med Int Health (2013) 1.50
A retrospective investigation on canine papillomavirus 1 (CPV1) in oral oncogenesis reveals dogs are not a suitable animal model for high-risk HPV-induced oral cancer. PLoS One (2014) 1.49
The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting. Br J Cancer (2007) 1.45
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. Br J Cancer (2006) 1.43
Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. Br J Cancer (2010) 1.41
Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr (2007) 1.39
Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA. J Clin Microbiol (2006) 1.38
The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa. BMC Infect Dis (2007) 1.36
Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas. J Clin Microbiol (2006) 1.36
Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC Infect Dis (2010) 1.35
Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis (2009) 1.35
Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. J Virol (2004) 1.34
HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study. Br J Cancer (2007) 1.30
Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States. Ann Intern Med (2009) 1.29
Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73. EMBO Rep (2006) 1.24
Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine. Vaccine (2009) 1.24
Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int J Cancer (2009) 1.22
Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16. Int J Cancer (2012) 1.21
Cancer screening in patients infected with HIV. Curr HIV/AIDS Rep (2011) 1.21
Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test. J Clin Microbiol (2007) 1.20
Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma. Int J Oncol (2013) 1.19
Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer. J Clin Microbiol (2010) 1.19
Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis. Carcinogenesis (2009) 1.19
Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. Br J Cancer (2005) 1.18
Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis. Br J Cancer (2004) 1.18
Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization. Infect Agent Cancer (2012) 1.17
Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer. Br J Cancer (2003) 1.17
Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses. Virology (2006) 1.16
Human Papillomavirus type distribution in invasive cervical cancer in Uganda. BMC Infect Dis (2008) 1.12
Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions. BMC Cancer (2008) 1.11
Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype. Am J Pathol (2010) 1.10
Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health (2008) 1.09
The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol Mol Biol Rev (2009) 1.09
Human papilloma virus (HPV) infection in children and adolescents. Eur J Pediatr (2008) 1.09
Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination. Am J Epidemiol (2013) 1.09
Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med (2007) 1.09
Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranes. J Clin Microbiol (2011) 1.09
Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits. Virol J (2012) 1.08
Prevalence of human papillomavirus infection in women in Benin, West Africa. Virol J (2011) 1.08
Cervical cancer risk factors among HIV-infected Nigerian women. BMC Public Health (2013) 1.07
Human papillomavirus infection in men who have sex with men in Lima, Peru. AIDS Res Hum Retroviruses (2012) 1.05
High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology (2006) 1.05
Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy. J Clin Microbiol (2014) 1.04
Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. J Clin Microbiol (2009) 1.04
Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III. Gynecol Oncol (2007) 1.03
Clinical and biological characteristics of cervical neoplasias with FGFR3 mutation. Mol Cancer (2005) 1.02
The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification. J Virol (2010) 1.02
Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women. Infect Agent Cancer (2011) 1.00
Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes. J Virol (2014) 1.00
Cervicovaginal self-sampling is a reliable method for determination of prevalence of human papillomavirus genotypes in women aged 20 to 30 years. J Clin Microbiol (2011) 1.00
Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination. Am J Public Health (2013) 0.99
Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins. Infect Agent Cancer (2006) 0.99
Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response. Viruses (2013) 0.99
Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana. Int J Gynecol Pathol (2011) 0.99
Prospective study of human papillomavirus and risk of cervical adenocarcinoma. Int J Cancer (2010) 0.98
Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN). Int J Infect Dis (2010) 0.98
High-risk human papillomavirus (HPV) screening and detection in healthy patient saliva samples: a pilot study. BMC Oral Health (2011) 0.98
Prevalence of HPV Infection And Cervical Intraepithelial Neoplasia And Attitudes towards HPV Vaccination among Chinese Women Aged 18-25 in Jiangsu Province. Chin J Cancer Res (2011) 0.97
High-Risk HPVs and Human Carcinomas in the Syrian Population. Front Oncol (2014) 0.97
Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China. PLoS One (2013) 0.96
Can routine posttransplant HPV vaccination prevent commonly occurring epithelial cancers after allogeneic stem cell transplantation? Clin Cancer Res (2009) 0.96
The occurrence of rare cancers in U.S. adults, 1995-2004. Public Health Rep (2010) 0.96
High risk HPV types 18 and 16 are potent modulators of oral squamous cell carcinoma phenotypes in vitro. Infect Agent Cancer (2007) 0.96
Prevalence of human papillomavirus in Indonesia: a population-based study in three regions. Br J Cancer (2008) 0.96
Prevalence of cervical neoplastic lesions and Human Papilloma Virus infection in Egypt: National Cervical Cancer Screening Project. Infect Agent Cancer (2007) 0.95
Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis. PLoS One (2011) 0.95
Normal and abnormal epithelial differentiation in the female reproductive tract. Differentiation (2011) 0.95
RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus. J Clin Microbiol (2009) 0.95
Prevalence and distribution of human papillomavirus infection in Korean women as determined by restriction fragment mass polymorphism assay. J Korean Med Sci (2012) 0.94
Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction. J Low Genit Tract Dis (2014) 0.94
The case for semi-mandatory HPV vaccination in China. Nat Biotechnol (2013) 0.94
Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study). BMC Cancer (2013) 0.94
The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women. Virol J (2014) 0.94
Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression. J Virol (2004) 0.94
Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia without colposcopic tissue information; a step toward automation for low resource settings. J Biomed Opt (2012) 0.93
Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a population-based study. Infect Agent Cancer (2013) 0.93
Human viruses and cancer. Viruses (2014) 0.92
Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer (2007) 0.92
Characterization of the plasma membrane localization and orientation of HPV16 E5 for cell-cell fusion. Virology (2009) 0.92
Human papillomavirus types 52 and 58 are prevalent in uterine cervical squamous lesions from Japanese women. Patholog Res Int (2011) 0.92
Exposure profiles and human papillomavirus infection in skin cancer: an analysis of 25 genus beta-types in a population-based study. J Invest Dermatol (2008) 0.92
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ (1980) 15.47
A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med (2002) 10.58
The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol (1995) 10.07
Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer (1999) 8.61
Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol (1999) 6.45
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol (1997) 5.76
Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis (1994) 4.89
The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer (1992) 3.88
Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol (1995) 3.26
Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol (1992) 2.60
Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst (1996) 2.30
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis (2000) 2.24
Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer (1994) 2.23
Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol (1991) 2.19
Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol (2001) 2.18
Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet (2001) 2.05
Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol (2000) 1.97
The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene (1989) 1.94
Risk factors for rapid-onset cervical cancer. Am J Obstet Gynecol (1999) 1.91
The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer (1998) 1.69
Human papillomavirus and mixed epithelial tumors of the endometrium. Hum Pathol (1998) 1.66
The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer (2001) 1.48
A direct comparison of methods proposed for use in widespread screening of human papillomavirus infections. Mol Cell Probes (1991) 1.34
Type of human papillomavirus is related to clinical features of cervical carcinoma. Cancer (1996) 1.23
Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer. Int J Cancer (2002) 1.21
Association of rare human papillomavirus types with genital premalignant and malignant lesions. J Infect Dis (1998) 1.19
Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy. Int J Radiat Oncol Biol Phys (2002) 1.14
Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland natives and Danish Caucasians. Microbes Infect (2000) 1.11
Current methods of testing for human papillomavirus. Best Pract Res Clin Obstet Gynaecol (2001) 1.08
HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. Cancer Epidemiol Biomarkers Prev (2001) 1.07
Cervical cancer in young women in Taiwan: prognosis is independent of papillomavirus or tumor cell type. Gynecol Oncol (1997) 0.98
Prevalence and genotyping of HPV in cervical cancer among Australian women. Int J Gynaecol Obstet (1999) 0.96
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet (1994) 4.85
Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst (2004) 4.83
Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell (1993) 4.66
Ryanodine modifies conductance and gating behavior of single Ca2+ release channel. Am J Physiol (1987) 4.61
Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer (2003) 4.40
A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ (1973) 4.22
Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst (2000) 3.81
Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin (2001) 3.65
Single channel measurements of the calcium release channel from skeletal muscle sarcoplasmic reticulum. Activation by Ca2+ and ATP and modulation by Mg2+. J Gen Physiol (1986) 3.55
Epizootic canine rabies transmitted by coyotes in south Texas. J Am Vet Med Assoc (1994) 3.43
Purified ryanodine receptor from skeletal muscle sarcoplasmic reticulum is the Ca2+-permeable pore of the calcium release channel. J Biol Chem (1987) 3.25
Sarcoplasmic reticulum contains adenine nucleotide-activated calcium channels. Nature (1985) 3.13
Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol (1993) 3.12
Morbidity from acute carbon monoxide poisoning at three-year follow-up. Br Med J (1973) 3.00
Risk factors for cervical cancer in Colombia and Spain. Int J Cancer (1992) 2.75
Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer (1994) 2.74
Limits of body mass index to detect obesity and predict body composition. Nutrition (2001) 2.69
Prospective study of blunt aortic injury: Multicenter Trial of the American Association for the Surgery of Trauma. J Trauma (1997) 2.60
Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol (1992) 2.60
Epidemiology of biliary tract cancers: an update. Ann Oncol (2008) 2.51
The ascension of wildlife rabies: a cause for public health concern or intervention? Emerg Infect Dis (1996) 2.45
Seasonal variation of blood pressure and its relationship to ambient temperature in an elderly population. J Hypertens (1993) 2.40
Cloning and expression of cDNA and genomic clones encoding three delayed rectifier potassium channels in rat brain. Neuron (1990) 2.38
Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev (1997) 2.36
Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer (2004) 2.33
A rapid tissue culture test for determining rabies neutralizing antibody. Monogr Ser World Health Organ (1973) 2.29
Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer (2006) 2.27
Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer (2002) 2.25
Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer (1994) 2.23
Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer (2001) 2.22
Medium supplementation for growth of Campylobacter pyloridis. J Clin Microbiol (1987) 2.20
Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst (1998) 2.19
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control (1999) 2.08
Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol (2000) 2.06
The investigation of dementia: results in 200 consecutive admissions. Lancet (1981) 2.01
Epidemiologic characteristics of rabies virus variants in dogs and cats in the United States, 1999. J Am Vet Med Assoc (2001) 2.01
Demonstration of antigenic variation among rabies virus isolates by using monoclonal antibodies to nucleocapsid proteins. J Clin Microbiol (1986) 2.00
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age. Br J Cancer (2011) 1.96
Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst (1996) 1.96
Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int J Cancer (1975) 1.95
Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med (1998) 1.95
Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer (2009) 1.95
Fish consumption and cancer risk. Am J Clin Nutr (1999) 1.94
The epidemiology of endometrial cancer. Gynecol Oncol (1991) 1.94
Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer (1999) 1.91
Population attributable risk for breast cancer: diet, nutrition, and physical exercise. J Natl Cancer Inst (1998) 1.91
Milker's nodule virus infections in Dorset and their similarity to orf. Nature (1965) 1.90
Intraoperative detection of myocardial ischemia in high-risk patients: electrocardiography versus two-dimensional transesophageal echocardiography. Circulation (1985) 1.88
Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer (2007) 1.87
"Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet (1984) 1.87
Single channel and 45Ca2+ flux measurements of the cardiac sarcoplasmic reticulum calcium channel. Biophys J (1986) 1.85
Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res (2001) 1.85
Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer (2006) 1.83
Family history and the risk of stomach and colorectal cancer. Cancer (1992) 1.83
Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer (2002) 1.83
Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res (1998) 1.80
International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer (2000) 1.79
Papillomavirus infection in rural women in southern India. Br J Cancer (2005) 1.79
Acute carbon monoxide poisoning--3 years experience in a defined population. Postgrad Med J (1970) 1.76
A case-control study of diabetes mellitus and cancer risk. Br J Cancer (1994) 1.76
Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer (2001) 1.75
Classic kaposi sarcoma: epidemiology and risk factors. Cancer (2000) 1.74
Histologic types of gastric carcinoma in high- and low-risk areas. Int J Cancer (1968) 1.73
Antigenic characteristics of isolates associated with a new epizootic of raccoon rabies in the United States. J Infect Dis (1984) 1.72
Epidemiology of bladder cancer in Alexandria, Egypt: tobacco smoking. Int J Cancer (1997) 1.71
A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control (2000) 1.70
The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer (1998) 1.69
Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer (1997) 1.68
Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol (2012) 1.68
Rabies surveillance in the United States during 1993. J Am Vet Med Assoc (1994) 1.67
The role of reproductive and menstrual factors in cancer of the breast before and after menopause. Eur J Cancer (1996) 1.67
Maize simple repetitive DNA sequences: abundance and allele variation. Genome (1996) 1.66
Genital warts and cervical neoplasia: an epidemiological study. Br J Cancer (1983) 1.65
Intratype variation in 12 human papillomavirus types: a worldwide perspective. J Virol (1996) 1.65
Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for specific nutrients. Ann Epidemiol (1996) 1.64
Oestrogens and obesity as risk factors for endometrial cancer in Italy. Int J Epidemiol (1982) 1.64
Dorsal thoracic arachnoid web and the "scalpel sign": a distinct clinical-radiologic entity. AJNR Am J Neuroradiol (2013) 1.62
Human papillomavirus infection in Shenyang City, People's Republic of China: A population-based study. Br J Cancer (2006) 1.62
Sexual factors, venereal diseases, and the risk of intraepithelial and invasive cervical neoplasia. Cancer (1986) 1.61
Olive oil, other dietary fats, and the risk of breast cancer (Italy). Cancer Causes Control (1995) 1.61
The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer (1996) 1.61
Postexposure trial of a human diploid cell strain rabies vaccine. J Infect Dis (1980) 1.58
The comparison of injury severity instrument performance using likelihood ratio and ROC curve analyses. J Trauma (1995) 1.58
Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections. Mod Pathol (2001) 1.58
Construction of a large-insert yeast artificial chromosome library of the mouse genome. Mamm Genome (1993) 1.58
Cancer of the oral cavity and pharynx in nonsmokers who drink alcohol and in nondrinkers who smoke tobacco. J Natl Cancer Inst (1998) 1.58